Inactive Instrument
Earth Science Tech, Inc. Share Price Other OTC
Stocks
ETST
US2703111037
Pharmaceuticals
OTC Markets Traded| Market Cap | 46.11M 40.43M 37.26M 34.89M 65.42M 4.35B 66.78M 448M 173M 2.15B 173M 169M 7.45B | P/E 2027 * |
5.33x | P/E 2028 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 46.11M 40.43M 37.26M 34.89M 65.42M 4.35B 66.78M 448M 173M 2.15B 173M 169M 7.45B | EV / Sales 2027 * |
1.07x | EV / Sales 2028 * | 1.05x |
| Free-Float |
33.3% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Earth Science Tech, Inc.
| 1 day | -5.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 46 | 12/02/2023 |
Ernesto Flores
DFI | Director of Finance/CFO | 41 | 03/03/2024 |
Mario Tabraue
PSD | President | 47 | 31/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Tabraue
BRD | Director/Board Member | 47 | 31/10/2021 |
Jeff Cazeau
BRD | Director/Board Member | 58 | 12/02/2023 |
Giorgio Saumat
CHM | Chairman | 46 | 30/09/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.08% | -10.57% | - | - | 46.11M | |
| +7.13% | +9.97% | +55.80% | +163.38% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +56.27% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.19% | 448B | |
| +0.27% | +4.85% | +28.17% | +22.04% | 332B | |
| -0.24% | +7.49% | +41.17% | +27.14% | 293B | |
| -0.74% | +4.39% | +30.56% | +40.87% | 286B | |
| -1.45% | +4.35% | -28.80% | -41.32% | 215B | |
| +1.56% | +6.14% | +29.30% | +61.91% | 193B | |
| +3.26% | +3.33% | +15.55% | +67.87% | 159B | |
| Average | +1.28% | +8.48% | +30.87% | +54.37% | 401.79B | |
| Weighted average by Cap. | +3.40% | +9.65% | +41.70% | +80.80% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.99M 37.69M 34.74M 32.53M 60.99M 4.05B 62.26M 418M 162M 2B 161M 158M 6.95B | 43.98M 38.56M 35.55M 33.28M 62.4M 4.15B 63.7M 427M 165M 2.05B 165M 162M 7.11B |
| Net income | - | 4.94 4.34 4 3.74 7.02 466.47 7.16 48.04 18.59 230.54 18.57 18.16 799.42 |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
